NOVN.SW vs. NOV
Compare and contrast key facts about Novartis AG (NOVN.SW) and National Oilwell Varco, Inc. (NOV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NOVN.SW or NOV.
Correlation
The correlation between NOVN.SW and NOV is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
NOVN.SW vs. NOV - Performance Comparison
Key characteristics
NOVN.SW:
0.22
NOV:
-0.79
NOVN.SW:
0.58
NOV:
-1.03
NOVN.SW:
1.09
NOV:
0.86
NOVN.SW:
0.43
NOV:
-0.39
NOVN.SW:
1.05
NOV:
-1.39
NOVN.SW:
6.89%
NOV:
23.81%
NOVN.SW:
19.88%
NOV:
42.08%
NOVN.SW:
-42.25%
NOV:
-89.77%
NOVN.SW:
-8.69%
NOV:
-83.37%
Fundamentals
NOVN.SW:
CHF 186.07B
NOV:
$4.47B
NOVN.SW:
CHF 5.27
NOV:
$1.49
NOVN.SW:
17.88
NOV:
7.98
NOVN.SW:
1.36
NOV:
0.27
NOVN.SW:
3.50
NOV:
0.51
NOVN.SW:
5.87
NOV:
0.72
NOVN.SW:
CHF 53.22B
NOV:
$8.82B
NOVN.SW:
CHF 40.26B
NOV:
$2.13B
NOVN.SW:
CHF 16.05B
NOV:
$1.22B
Returns By Period
In the year-to-date period, NOVN.SW achieves a 6.39% return, which is significantly higher than NOV's -14.47% return. Over the past 10 years, NOVN.SW has outperformed NOV with an annualized return of 5.51%, while NOV has yielded a comparatively lower -12.17% annualized return.
NOVN.SW
6.39%
2.79%
1.47%
4.23%
7.25%
5.51%
NOV
-14.47%
11.79%
-24.09%
-33.09%
-0.26%
-12.17%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NOVN.SW vs. NOV — Risk-Adjusted Performance Rank
NOVN.SW
NOV
NOVN.SW vs. NOV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NOVN.SW) and National Oilwell Varco, Inc. (NOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NOVN.SW vs. NOV - Dividend Comparison
NOVN.SW's dividend yield for the trailing twelve months is around 3.84%, more than NOV's 2.42% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NOVN.SW Novartis AG | 3.84% | 3.72% | 3.77% | 3.91% | 3.94% | 3.72% | 3.27% | 3.98% | 3.98% | 4.35% | 3.58% | 3.17% |
NOV National Oilwell Varco, Inc. | 2.42% | 1.88% | 0.99% | 0.96% | 0.37% | 0.36% | 0.80% | 0.78% | 0.56% | 1.63% | 5.49% | 2.46% |
Drawdowns
NOVN.SW vs. NOV - Drawdown Comparison
The maximum NOVN.SW drawdown since its inception was -42.25%, smaller than the maximum NOV drawdown of -89.77%. Use the drawdown chart below to compare losses from any high point for NOVN.SW and NOV. For additional features, visit the drawdowns tool.
Volatility
NOVN.SW vs. NOV - Volatility Comparison
The current volatility for Novartis AG (NOVN.SW) is 11.85%, while National Oilwell Varco, Inc. (NOV) has a volatility of 20.37%. This indicates that NOVN.SW experiences smaller price fluctuations and is considered to be less risky than NOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
NOVN.SW vs. NOV - Financials Comparison
This section allows you to compare key financial metrics between Novartis AG and National Oilwell Varco, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
NOVN.SW vs. NOV - Profitability Comparison
NOVN.SW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Novartis AG reported a gross profit of 10.39B and revenue of 13.62B. Therefore, the gross margin over that period was 76.3%.
NOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, National Oilwell Varco, Inc. reported a gross profit of 447.00M and revenue of 2.10B. Therefore, the gross margin over that period was 21.3%.
NOVN.SW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Novartis AG reported an operating income of 4.66B and revenue of 13.62B, resulting in an operating margin of 34.2%.
NOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, National Oilwell Varco, Inc. reported an operating income of 152.00M and revenue of 2.10B, resulting in an operating margin of 7.2%.
NOVN.SW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Novartis AG reported a net income of 3.61B and revenue of 13.62B, resulting in a net margin of 26.5%.
NOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, National Oilwell Varco, Inc. reported a net income of 73.00M and revenue of 2.10B, resulting in a net margin of 3.5%.